These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38167290)

  • 1. The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients.
    Muyas F; Rodriguez MJG; Cascão R; Afonso A; Sauer CM; Faria CC; Cortés-Ciriano I; Flores I
    Nat Commun; 2024 Jan; 15(1):82. PubMed ID: 38167290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere Length Dynamics and the Evolution of Cancer Genome Architecture.
    Cleal K; Norris K; Baird D
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALT: A Multi-Faceted Phenomenon.
    Sommer A; Royle NJ
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres.
    Lippert TP; Marzec P; Idilli AI; Sarek G; Vancevska A; Bower M; Farrell PJ; Ojala PM; Feldhahn N; Boulton SJ
    Nat Commun; 2021 Jan; 12(1):512. PubMed ID: 33479235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of telomere maintenance mechanisms.
    Hakobyan M; Binder H; Arakelyan A
    J Biol Chem; 2024 Jun; 300(6):107392. PubMed ID: 38763334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere sequence content can be used to determine ALT activity in tumours.
    Lee M; Teber ET; Holmes O; Nones K; Patch AM; Dagg RA; Lau LMS; Lee JH; Napier CE; Arthur JW; Grimmond SM; Hayward NK; Johansson PA; Mann GJ; Scolyer RA; Wilmott JS; Reddel RR; Pearson JV; Waddell N; Pickett HA
    Nucleic Acids Res; 2018 Jun; 46(10):4903-4918. PubMed ID: 29718321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
    Zhao S; Wang F; Liu L
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Molecule Telomere Assay via Optical Mapping (SMTA-OM) Can Potentially Define the ALT Positivity of Cancer.
    Raseley K; Jinwala Z; Zhang D; Xiao M
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
    Tang M; Li Y; Zhang Y; Chen Y; Huang W; Wang D; Zaug AJ; Liu D; Zhao Y; Cech TR; Ma W; Songyang Z
    J Cell Sci; 2015 Jan; 128(2):331-41. PubMed ID: 25416818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATRX modulates the escape from a telomere crisis.
    Geiller HEB; Harvey A; Jones RE; Grimstead JW; Cleal K; Hendrickson EA; Baird DM
    PLoS Genet; 2022 Nov; 18(11):e1010485. PubMed ID: 36350851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative lengthening of telomeres in cancer stem cells in vivo.
    Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
    Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
    Yuan X; Larsson C; Xu D
    Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
    Gocha ARS; Harris J; Groden J
    Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
    Apte MS; Cooper JP
    Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
    Gao J; Pickett HA
    Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
    Claude E; Decottignies A
    Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
    Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
    J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.